Charles Feldman to Anti-Infective Agents
This is a "connection" page, showing publications Charles Feldman has written about Anti-Infective Agents.
Connection Strength
0,395
-
An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia. Int J Antimicrob Agents. 2001 Mar; 17(3):177-88.
Score: 0,180
-
Guideline for the management of nosocomial infections in South Africa. S Afr Med J. 2006 Jul; 96(7 Pt 2):642-52.
Score: 0,065
-
Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Arch Immunol Ther Exp (Warsz). 2005 May-Jun; 53(3):189-98.
Score: 0,060
-
From guidelines to practice: a pharmacist-driven prospective audit and feedback improvement model for peri-operative antibiotic prophylaxis in 34 South African hospitals. J Antimicrob Chemother. 2017 04 01; 72(4):1227-1234.
Score: 0,034
-
CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS. J Intensive Care Med. 2011 Jan-Feb; 26(1):34-40.
Score: 0,022
-
Emergence of extensive drug resistance (XDR) among Gram-negative bacilli in South Africa looms nearer. S Afr Med J. 2008 Aug; 98(8):586, 588, 590 passim.
Score: 0,019
-
Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis. 2004 Jul; 4(7):445-55.
Score: 0,014